PENGGUNAAN PELEMBAP PADA BAYI BERISIKO TINGGI TERHADAP INSIDENS DERMATITIS ATOPIK INFANTIL: SEBUAH TELAAH SISTEMATIK

Authors

  • Endi Novianto
  • Vanessa Aryani Octavia Mardani Dokter Magang Divisi Alergo-Imunologi Departemen Dermatologi & Venereologi FK Universitas Indonesia/RSUPN dr. Cipto Mangunkusumo, Jakarta

DOI:

https://doi.org/10.33820/mdvi.v47i4.365

Keywords:

atopi, bayi, dermatitis, pelembab, pencegahan

Abstract

Introduction: Atopic dermatitis is a relapsing chronic inflammatory skin disease, 15-20% occurring in children. Heredity in the family is the most crucial risk factor for the incidence of atopic dermatitis. Therefore, improving the barrier function of the skin as early as possible in high-risk infants may be an option as primary prevention for atopic dermatitis. Objective: Conducting a systematic review of randomized controlled trials (RCT) that test the effects of giving moisturizers to high-risk infants and the incidence of infantile atopic dermatitis. Methods: A literature search was carried out through three electronic databases: PubMed, Cochrane, and Embase. Those articles were critically reviewed and assessed for the risk of bias using the Cochrane Risk of Bias Tools. Results: After a critical review of the full text, there were 4 RCT articles. Those four articles found a similar outcome: the incidence of atopic dermatitis was lower in the intervention group. Discussion: The link between heredity and the incidence of atopic dermatitis in children forms the basis of inclusion criteria for samples in this systematic review. Moisturizer administration has been shown to improve TEWL values and stratum corneum hydration. Conclusion: The use of moisturizers in high-risk infants may be considered as one of the preventive interventions for atopic dermatitis. However, further research is needed to support this hypothesis.

Downloads

Download data is not yet available.

References

1. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(1):8–16.
2. Yong AMY, Tay Y-K. Atopic dermatitis:racial and ethnic differences. Dermatol Clin. 2017;35(3):395-402.
3. Vrebova M, Dorociakova P, Vyskovsky R, Murinova LP, Ciznar P, Rausova K, dkk. Dynamics of allergy development during the first 5 years of life. Eur J Pediatr. 2018;177(9):1317-1325.
4. Tsakok T, Woolf R, Smith CH, Weidinger S, Flohr C. Atopic dermatitis: the skin barrier and beyond. Br J Dermatol. 2019;180(3):464-74.
5. Eichenfield LF, Boguniewicz M, Simpson EL, Russell JJ, Block JK, Feldman SR, dkk. Translating atopic dermatitis management guidelines into practice for primary care providers. Pediatrics. 2015;136(3):554-65.
6. Roduit C, Frei R, Depner M, Karvonen AM, Renz H, Braun- Fahrlander C, dkk. Phenotypes of atopic dermatitis depending on the timing of onset and progression in childhood. JAMA Pediatr. 2017;171(7):655-62
7. Paller AS, Spergel JM, Mina-Osorio P, Irvine AD. The atopic march and atopic multimorbidity: many trajectories, many pathways. J Allergy Clin Immunol. 2019;143(1):46-55.
8. Fuxench ZCC. Atopic dermatitis: disease background and risk factors. Adv Exp Med Biol.2017;1027:11-19..
9. Yepes-Nunez JJ, Brozek JL, Fiocchi A, Pawankar R, Cuello- Garcia C, Zhang Y, dkk. Vitamin D supplementation in primary allergy prevention: systematic review of randomized and non- randomized studies. Allergy. 2018;73(1):37-49.
10. Boyle RJ, Ierodiakonou D, Khan T, Chivinge J, Robinson Z, Geoghegan N, dkk. Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta- analysis. BMJ. 2016;352:i974.
11. Chang YS, Trivedi MK, Jha A, Lin YF, Dimaano L, Garcia- Romero MT. Synbiotics for prevention and treatment of atopic dermatitis: a meta-analysis of randomized clinical trials. JAMA Pediatr. 2016;170(3):236-42.
12. Kelleher M, Dunn-Galvin A, Hourihane J O'B, Murray D, Campbell LE, McLean WHI, dkk. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol. 2015;135(4):930-5.
13. Horimukai K, Morita K, Narita M, Kondo M, Kabashima S, Inoue E, dkk. Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations. Allergol Int. 2016;65(1):103-8
172
Novianto E. dan Mardani VAO Penggunaan pelembap pada bayi berisiko tinggi terhadap insidens DA infantil
14. Thitthiwong P, Koopitakkajorn T. The good skin care practices and emollient use since early infancy as the primary prevention of infantile atopic dermatitis among infants at risk: a randomized controlled trial . Siriraj Med J. 2020;72(1):41-6.
15. Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WH, dkk. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134(4):818-23.
16. Horimukai K, Morita K, Narita M, Kondo M, Kitazawa H, Nozaki M, dkk. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014;134(4):824-30.
17. McClanahan D, Wong A, Kezic S, Samrao A, Hajar T, Hill E, dkk. A randomized controlled trial of an emollient with ceramide and filaggrin-associated amino acids for the primary prevention of atopic dermatitis in high-risk infants. JEADV. 2019;33(11):2087-94.
18. Ravn NH, Halling AS, Berkowitz AG, Rinnov MR, Silverberg JI, Egeberg A, dkk. How does parental history of atopic disease predict the risk of atopic dermatitis in a child? a systematic review and meta-analysis. J Allergy Clin Immunol. 2019;S0091-6749(19):32606-5.
19. Hon KL, Tsang YCK, Poon TCW, Pong NH, Kwan M, Lau S, dkk. Predicting eczema severity beyond childhood. World J Pediatr. 2016;12(1):44-8.
20. Blume-Peytavi U, Lavender T, Jenerowicz D, Ryumina I, Stalder JF, Torrelo A, dkk. Recommendations from a european roundtable meeting on best practice healthy infant skin care. Pediatr Dermatol. 2016;33(3):311-2.
21. Bhanot A, Huntley A, Ridd MJ. Adverse events from emollient use in eczema: a restricted review of published data. 2019;9(2):193-208.
22. Sawatzky S, Schario M, Stroux A, Lunnemann L, Zuberbier T, Blume-Peytavi U, dkk. Children with dry skin and atopic predisposition: outcome measurement with validated scored for atopic dermatitis. Skin Pharmacol Physiol. 2016;29(3):148-56.
23. Glatz M, Jo JH, Kennedy EA, Polley EC, Segre JA, Simpson EL, dkk. Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis. PloS One. 2018;13(2):e0192443.

Published

2022-07-12

How to Cite

Novianto, E., & Mardani, V. A. O. (2022). PENGGUNAAN PELEMBAP PADA BAYI BERISIKO TINGGI TERHADAP INSIDENS DERMATITIS ATOPIK INFANTIL: SEBUAH TELAAH SISTEMATIK. Media Dermato-Venereologica Indonesiana, 47(4), 168–173. https://doi.org/10.33820/mdvi.v47i4.365

Issue

Section

Artikel Asli